Analysis fo patient age as an independent prognostic factor for survival in a phase III study of cisplatin-cyclophosphamide versus carboplatin-cyclophosphamide in stage III(suboptimal) and IV ovarian cancer. A Southwest Oncology Group study.

• ALBERTS D. S.

収録刊行物

• Cancer

  Cancer 71 618-, 1993

詳細情報

• CRID: 1571980074565427200
• NII論文ID: 10008108513
• データソース種別:
  • CiNii Articles